CV vs. LLY
CV (CapsoVision, Inc) and LLY (Eli Lilly and Company) are both stocks. Both are in the Healthcare sector — CV in Medical Devices, LLY in Drug Manufacturers - General. At a 0.11 correlation, their price movements are largely independent.
Performance
CV vs. LLY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CV achieves a -32.74% return, which is significantly lower than LLY's 5.64% return.
CV
- 1D
- -4.64%
- 1M
- 2.57%
- YTD
- -32.74%
- 6M
- 4.20%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
LLY
- 1D
- 0.55%
- 1M
- 14.82%
- YTD
- 5.64%
- 6M
- 12.37%
- 1Y
- 48.81%
- 3Y*
- 37.66%
- 5Y*
- 42.48%
- 10Y*
- 33.36%
CV vs. LLY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
CV CapsoVision, Inc | -32.74% | 205.43% |
LLY Eli Lilly and Company | 5.64% | 38.41% |
Correlation
The correlation between CV and LLY is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Jul 3, 2025 | 0.11 |
Fundamentals
CV:
$341.22M
LLY:
$1.01T
CV:
-$0.28
LLY:
$28.14
CV:
51.10
LLY:
14.06
CV:
16.88
LLY:
32.49
CV:
$13.56M
LLY:
$72.25B
CV:
$7.01M
LLY:
$59.75B
CV:
-$19.70M
LLY:
$32.97B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CV vs. LLY — Risk / Return Rank
CV
LLY
CV vs. LLY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for CapsoVision, Inc (CV) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Sharpe Ratios by Period
| CV | LLY | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | 1.29 | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 1.30 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 1.11 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 1.14 | 0.58 | +0.56 |
Drawdowns
CV vs. LLY - Drawdown Comparison
The maximum CV drawdown since its inception was -67.82%, roughly equal to the maximum LLY drawdown of -68.24%. Use the drawdown chart below to compare losses from any high point for CV and LLY.
Loading charts...
Drawdown Indicators
| CV | LLY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -67.82% | -68.24% | +0.42% |
Max Drawdown (1Y)Largest decline over 1 year | — | -23.64% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -34.48% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -34.48% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -34.48% | — |
Current DrawdownCurrent decline from peak | -50.14% | 0.00% | -50.14% |
Average DrawdownAverage peak-to-trough decline | -31.15% | -19.22% | -11.93% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 9.49% | — |
Volatility
CV vs. LLY - Volatility Comparison
Loading charts...
Volatility by Period
| CV | LLY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 9.72% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 27.08% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 103.79% | 38.06% | +65.73% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 103.79% | 32.83% | +70.96% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 103.79% | 30.17% | +73.62% |
Dividends
CV vs. LLY - Dividend Comparison
CV has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.57%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CV CapsoVision, Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LLY Eli Lilly and Company | 0.57% | 0.56% | 0.67% | 0.78% | 1.07% | 1.23% | 1.75% | 1.96% | 1.94% | 2.46% | 2.77% | 2.37% |
Financials
CV vs. LLY - Financials Comparison
This section allows you to compare key financial metrics between CapsoVision, Inc and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CV and LLY have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for CV and LLY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer